Expression of the insulin‐like growth factor system and cancer progression in hormone‐treated prostate cancer patients

Abstract

In the IGF system, IGF-II and IGFBP-2 play a role in human prostate cancer progression and their increased expression is a possible candidate for a prognostic indicator in hormone-treated prostate cancer patients.